Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition

Home > Science Hub > Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition
Back to the list

February 7, 2020

Couetoux du Tertre et al. Clin Proteom 2020;17:5.

Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition

Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition

Download publication

You might also be interested by

Brochures

Immuno-MRM Assays

August 4, 2023

Proteomics/Mass Spectrometry

More info

Webinars

Precision Oncology Approaches: Using Proteomics to Build Next-Gen Diagnostic Solutions

May 2, 2023

Proteomics/Mass Spectrometry

More info

Posters

Analytical characterization of a multiplex panel measuring 45 cytokines by proximity extension assay in plasma from subjects with NSCLC

April 17, 2023

Proteomics/Mass Spectrometry

More info

Brochures

Empower Cancer Research with Proteomics

April 11, 2023

Proteomics/Mass Spectrometry

More info